Skechers to be acquired by 3G Capital in take-private deal, shares soar 25%

Skechers to be acquired by 3G Capital in take-private deal, shares soar 25%


The entrance of the Sketchers retail store at the Barton Creek Square Mall on July 16, 2024 in Austin, Texas. 

Brandon Bell | Getty Images

Footwear giant Skechers has agreed to be acquired by private equity firm 3G Capital for $63 per share, ending its nearly three-decade run as a public company, the retailer announced on Monday.

The price 3G Capital agreed to pay represents a 30% premium to Skechers’ current valuation on the public markets, which is line with similar takeover deals. Shares of Skechers soared more than 25% after the transaction was announced.

“With a proven track-record, Skechers is entering its next chapter in partnership with the global investment firm 3G Capital,” Skechers’ CEO Robert Greenberg said in a news release.

“Given their remarkable history of facilitating the success of some of the most iconic global consumer businesses, we believe this partnership will support our talented team as they execute their expertise to meet the needs of our consumers and customers while enabling the Company’s long-term growth,” he said.

The transaction comes at a difficult time for the retail industry and in particular, the footwear sector, which relies on discretionary spending and overseas supply chains that are now in the crosshairs of President Donald Trump’s trade war. 

Last week Skechers signed onto a letter penned by the Footwear Distributors and Retailers of America trade group asking for an exemption from Trump’s tariffs.

And, a little over a week ago, Skechers withdrew its full-year 2025 guidance “due to macroeconomic uncertainty stemming from global trade policies” as companies brace for a drop in consumer spending that will disproportionately impact the footwear and apparel sectors. 

Skechers declined to say how much of its supply chain is based in China, which is currently facing 145% tariffs, but cautioned that two-thirds of its business is outside of the U.S. and therefore won’t see as much of an impact. 

A source close to the deal said the trade environment didn’t force Skechers into a deal and that 3G Capital had been interested in acquiring the company for years.

Tariffs do present some uncertainty in the short term, but 3G Capital believes the long-term outlook of Skechers’ business remains attractive and is well positioned for growth, the person said.

Skechers is the third-largest footwear company in the world behind Nike and Adidas.

Greenberg will stay on as Skechers’ CEO and continue enacting the company’s strategy after the acquisition is completed.



Source

Stellantis unveils new Jeep Cherokee as brand tries to shake off sales declines
Business

Stellantis unveils new Jeep Cherokee as brand tries to shake off sales declines

Jeep is rolling out a freshly designed model after six consecutive years of annual sales declines. The Stellantis automaker unveiled a new Jeep Cherokee on Thursday, the latest move to try to jump-start sales. It’s the first Jeep hybrid system, and the first for Stellantis in North America. The 2026 Jeep Cherokee redesign aims to […]

Read More
Cracker Barrel shares plummet after pushback on new logo, brand refresh
Business

Cracker Barrel shares plummet after pushback on new logo, brand refresh

The new Cracker Barrel logo is seen on a menu inside the restaurant on Aug. 21, 2025 in Homestead, Florida. Joe Raedle | Getty Images Shares of Cracker Barrel Old Country Store plummeted roughly 10% on Thursday after the restaurant unveiled its new logo earlier this week as part of a larger brand refresh. The […]

Read More
A new pharma factory shows how hard it could be for drugmakers to outrun Trump’s tariffs
Business

A new pharma factory shows how hard it could be for drugmakers to outrun Trump’s tariffs

HOLLY SPRINGS, N.C. — A hallway as long as three football fields connects four buildings at Fujifilm Biotechnologies’ new biologics manufacturing plant in Holly Springs, North Carolina. The first two buildings are preparing to open this fall to produce drug substance, essentially the base of biologic drugs, for Fujifilm’s initial customers Regeneron and Johnson & […]

Read More